Key result
11 C-Metomidate PET/CT aided clinical decision-making for lateralization and management in 15 patients with primary aldosteronism following equivocal or failed adrenal vein sampling.
Why the study?
Challenges with adrenal vein sampling for lateralizing aldosterone-producing adenomas in primary aldosteronism limit surgical eligibility, prompting evaluation of alternative strategies such as 11 C-Metomidate PET/CT.
Does 11C-Metomidate PET/CT aid in the lateralization and clinical decision-making for patients with primary aldosteronism?
Observational (n=15)
Does 11C-Metomidate PET/CT aid in the lateralization and clinical decision-making for patients with primary aldosteronism?
11C-Metomidate PET/CT serves as a useful adjunct to adrenal vein sampling for lateralizing aldosterone-producing adenomas in primary aldosteronism, aiding clinical decision-making.
May support adjunctive 11C-metomidate PET/CT in primary aldosteronism; hypothesis-generating and requires randomized validation.
No takes yet. Share an insight, caveat, or question.
Cheung et al. (2020) conducted an observational in Primary aldosteronism (n=15). 11 C-Metomidate PET/CT was evaluated on Individual lateralization and clinical outcomes (blood pressure, ARR, number of hypertensive medications). 11 C-Metomidate PET/CT aided clinical decision-making for lateralization and management in 15 patients with primary aldosteronism following equivocal or failed adrenal vein sampling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: